- Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment
-
Yap DYH, Liu KSH, Hsu YC, Wong GLH, Tsai MC, Chen CH, Hsu CS, Hui YT, Li MKK, Liu CH, Kan YM, Yu ML, Yuen MF
- KMID: 2507974
- Clin Mol Hepatol.
- 2020 Oct;26(4):554-561.
- doi: 10.3350/cmh.2020.0058
Background/Aims: Data on treatment efficacy and safety of glecaprevir/pibrentasvir (GLE/PIB) for chronic hepatitis C virus (HCV) infection in Asian patients with severe renal impairment are limited. This study aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum and Pleural Fluid Procalcitonin in Predicting Bacterial Infection in Patients with Parapneumonic Effusion
-
Ko YC, Wu WP, Hsu CS, Dai MP, Ou CC, Kao CH
- KMID: 1779154
- J Korean Med Sci.
- 2009 Jun;24(3):398-402.
- doi: 10.3346/jkms.2009.24.3.398
This study evaluated the value of procalcitonin (PCT) levels in pleural effusion to differentiate the etiology of parapneumonic effusion (PPE). Forty-one consecutive PPE patients were enrolled and were divided into... -
- CITED
-
- Close
- SHARE
-
- Close
